Israel Englander’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Israel Englander’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-50,000	Closed	-$5.75M	–	4507
2014 Q4	$5.75M	Buy	50,000 +20,000	+67%	+$2.42M	0.01%	1296
2014 Q3	$4.69M	Buy	+30,000	New	+$4.35M	0.01%	1332

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $487M AUM 49.37% 1-Year Est. Return

Israel Englander's SLXP Position: Q2 2015 in Review

Israel Englander sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 838,953 shares — an estimated $145M sold.

Israel Englander first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $145M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Israel Englander reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Israel Englander sold 838,953 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $145M.
Israel Englander first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Israel Englander's SALIX PHARMACEUTICALS LTD DEL position peaked at $145M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.